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concentrations of 0.02-0.25 mg/mL for CD analysis unless otherwise specified. The solution was placed in a quartz cell with a path length of 0.2 cm and the mean residue molar ellipticity of each polymer was calculated based on the measured apparent ellipticity according to the reported formulas: Ellipticity ([θ] in deg cm 2 dmol -1 ) = (millidegrees × mean residue weight)/(path length in millimeters × concentration of polypeptide in mg ml -1 ). The helicity of the polypeptides was calculated using the following equation: helicity = (−[θ 222 ] + 3,000)/39,000. [2] Lyophilization was performed on a FreeZone lyophilizer (Labconco, Kansas City, MO, USA).
Synthesis of Oleic Acid N-Hydroxysuccinimide Ester (Oleyl-NHS)
NHS (2.67 g, 23.2 mmol) and DIEA (2.72 mL, 15.6 mmol) were dissolved in THF (50 mL). The mixture was cooled in an ice bath to which oleoyl chloride (85%, 6.1 mL, 15.6 mmol)
was added dropwise over the course of 1 h. The mixture was allowed to stir at 0 o C for 2 h and then overnight at room temperature. The grey precipitate was removed by centrifugation. After the solvent was removed under vacuum, the resulting yellowish oil was dissolved in DCM (20 mL) and washed with 5% HCl (10 mL × 2). DCM was dried over MgSO 4 and then evaporated under vacuum to give the crude product. Oleyl-NHS was recrystallized from ethanol (yield 62%).
Synthesis and Characterization of Oleyl-Trimethyl Chitosan Chloride (OTMC)
Trimethyl chitosan chloride (TMC, MW = 200 kDa, quarternization degree of 28.7%) was synthesized as described previously. [3] TMC (50 mg, 0.28 mmol of NH 2 ) and oleyl-NHS Fig. S1 ). The quarternization degree was calculated by the integral ratio of trimethyl protons (c) to chitosan backbone C2-C6 protons (b). The oleyl conjugation degree was calculated by the integral ratio of oleyl protons (e) to trimethyl protons (c).
Synthesis and Characterization of Oleyl-PEG-Mannose (OPM)
Boc-PEG-mannose was obtained by reacting Boc-PEG-SVA with D-mannosamine in DMF. D-mannosamine hydrochloride (108 mg, 0.50 mmol) and 1,1,3,3-tetramethylguanidine (120 μL, 0.96 mmol) were dissolved in DMF (10 mL). The mixture was then added to a vial containing Boc-PEG-SVA (MW = 3.4 kDa, 340 mg, 0.10 mmol). The mixture was stirred for 48 h at 50 o C and dialyzed against DI water for 24 h (MWCO = 1 kDa). The product Boc-PEG-mannose was lyophilized (yield 74%) and characterized by MALDI-TOF-MS.
Individual peak shifts (relative to Boc-PEG-SVA) corresponding to the deduction of one NHS group and the addition of one mannosamine per PEG were observed (m/z = +64).
Boc-PEG-mannose (250 mg, 0.07 mmol) was deprotected by TFA/DCM (5.0 mL, 1:1, v/v) to yield NH 2 -PEG-mannose. The reaction was allowed to proceed for 1 h at room temperature. The polymer was then precipitated and washed with cold diethyl ether (20 mL × 2, yield 86%). The product (NH 2 -PEG-mannose) was characterized by MALDI-TOF-MS.
Individual peak shifts (relative to Boc-PEG-mannose) corresponding to the deduction of one Boc group per PEG were observed (m/z = -100). Figure S2) . Individual peak shifts (relative to NH 2 -PEG-mannose)
corresponding to the addition of one oleyl group per PEG were observed (m/z = +264).
Synthesis and Characterization of Oleyl-PEG-Cysteamine (OPC)
Cystamine dihydrochloride (113 mg, 0.50 mmol) and 1,1,3,3-tetramethylguanidine (120 μL, 0.96 mmol) were dissolved in acetonitrile (10 mL). The solution was then added to a vial containing Boc-PEG-SVA (MW = 3.4 kDa, 340 mg, 0.10 mmol). The mixture was stirred overnight at room temperature and dialyzed against DI water for 24 h (MWCO = 1 kDa). The product, Boc-PEG-cystamine, was lyophilized (yield 76%) and characterized by MALDI-TOF-MS. Individual peak shifts (relative to Boc-PEG-SVA) corresponding to the deduction of one NHS group and the addition of one cystamine per PEG were observed (m/z = +37).
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Boc-PEG-cystamine (250 mg, 0.07 mmol) was deprotected by TFA/DCM (5 mL, 1:1, v/v) to give NH 2 -PEG-cystamine. The reaction was allowed to proceed for 1 h at room temperature.
The polymer was then precipitated and washed with cold diethyl ether (20 mL × 2, yield 90%).
The product was characterized by MALDI-TOF-MS. Individual peak shifts (relative to Boc-PEG-cystamine) corresponding to the deduction of one Boc group per PEG were observed (m/z = -100).
Oleyl-PEG-cystamine-oleyl was synthesized by reacting oleyl-NHS (50.0 mg, 0. 
Preparation and Characterization of SSNPs
siRNA and sodium tripolyphosphate (TPP) were dissolved in DEPC-treated water at 0.2 mg/mL and 1 mg/mL, respectively, and then mixed at the siRNA/TPP weight ratio of 1:12.5.
OTMC, PVBLG-8, OPM, and OPC were separately dissolved in DEPC-treated water at 2 mg/mL, 1 mg/mL, 10 mg/mL, and 10 mg/mL, respectively and then mixed at the predetermined weight ratios of 5:1:5:5. Subsequently, the OTMC/PVBLG-8/OPM/OPC mixture was added to S8 siRNA/TPP at the OTMC/TPP weight ratio of 8:1 followed by vortexing for 30 s and incubation at 37 °C for 30 min. The obtained SSNPs were characterized for size and zeta potential using dynamic light scattering (DLS, Zetasizer Nano-ZS, Malvern). A gel retardation assay was used to evaluate siRNA condensation. Briefly, SSNPs or naked siRNA were loaded in 4% low-melting agarose gel followed by electrophoresis at 56 V for 1 h and visualization of siRNA migration by gel documentation. SSNPs were also characterized by SEM (4800, Hitachi, Japan). The stability of SSNPs against pH alteration, salt, and dilution was evaluated in terms of particle size and zeta potential. In order to evaluate the stability of SSNPs against salt and dilution, they were diluted with PBS (0.15 M, pH 6.8) up to 100-fold. To simulate the pH alteration in the gastrointestinal tract, the pH of the SSNPs suspension was adjusted to 1.2 using 1 N HCl and back to 6.8 using 1 N NaOH.
Stability of siRNA
In order to evaluate the in vivo stability of siRNA following oral administration, siRNA-containing SSNPs or naked siRNA was treated with mouse serum or intestinal fluids.
Blood was collected from the orbital sinus of male C57BL/6 mice and centrifuged at 12,000 rpm for 4 min to separate the serum. To prepare the intestinal fluids, mice were sacrificed and the whole small intestine was washed with cold PBS (2 mL, 0.2 M, pH 7.4) through insertion of a sonde needle into the upper side and cannulation on the lower side. The washed solution was centrifuged at 12,000 rpm and 4 °C for 20 min, and the supernatant was collected as the intestinal fluids. SSNPs (0.2 mL) were mixed with mouse serum or intestinal fluids (0.2 mL).
After incubation at 37 °C for 2 h, the mixture was heated at 80 °C for 5 min to deactivate the nucleases. Heparin (1000 U/mL) was added to dissociate the siRNA. The mixture was loaded on 4% agarose gel followed by electrophoresis at 56 V for 1 h and siRNA integrity visualization by gel documentation.
Mucoadhesion

S9
SSNPs (400 μL) were mixed with mucin solution (1 mL, 200 μg/mL) and incubated at 37 °C for 8 h. The solution was centrifuged at 12,000 rpm for 10 min. The mucin adsorption level was determined by harvesting the supernatant and measuring the remaining mucin content with a colorimetric method using periodic acid/Schiff staining. [4] Permeation Studies in Human FAE and Non-FAE models
To establish the human non-FAE model, Caco-2 cells were seeded on Millicell ® (pore size 0.4 μm, surface area 0.6 cm 2 , Millipore) at 5 × 10 4 cells/well and subsequently cultured for 21 days to form monolayers. 5 The media at both the apical (AP) and basolateral (BL) sides were replaced daily. The transepithelial electric resistance (TEER) values of monolayers reached 300-350 Ω/cm 2 after the 21-day culture.
To establish the FAE model, Caco-2 cells were cultured on Millicell ® for 16 days before Raji B cells were seeded on the BL side at 5×10 4 cells/well. The cells were co-cultured for another 7 days with media at the AP side being replaced daily. The TEER values of the co-cultured monolayers were similar to the mono-cultured cell monolayers (300-350 Ω/cm 2 ),
suggesting that the introduction of Raji cells did not alter the polarity of Caco-2 cells and the intercellular tight junctions [5] .
Cy3-siRNA containing SSNPs or naked Cy3-siRNA was added to the AP side of the FAE and non-FAE models in HBSS at 0.4 μg Cy3-siRNA/well. At selected time intervals, transepithelial electrical resistance (TEER) was measured and an aliquot of 50 μL was withdrawn from the BL side to quantify transported Cy3-siRNA. The apparent permeability coefficient (P app ) for Cy3-siRNA was calculated using the equation of
, where Q is the total amount of Cy3-siRNA permeated (ng), A is the diffusion area of the cell monolayers (cm 2 ), c is the initial concentration of Cy3-siRNA on the AP side (ng/cm 3 ), and t is the total time of the transport experiment (s).
After the 4-h transport study, Cy3-siRNA penetration/distribution in the cell monolayers was observed by CLSM (LSM 700, Zeiss, Germany) at optical sections with 5-μm in increment.
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The fluorescence intensity in each section was analyzed by Image J. To quantify the penetration of SSNPs, we defined the penetration depth as the distance from the periphery of the AP side to the site where the fluorescence intensity decreased by 95% as compared to the maximal fluorescent intensity of the SSNPs-treated cell monolayers at the apical periphery. The uptake level of Cy3-siRNA in the cell monolayers was also determined by lysing the monolayers with RIPA lysis buffer (500 μL) and quantifying the Cy3-siRNA content in the lysate. Results were expressed as ng of Cy3-siRNA per mg of cellular protein.
The tight junction protein-associated transport mechanism was evaluated by Table   S2 ). The ribosomal mRNA actin was used as an internal loading control, and its expression did not change over the 24 h period following addition of LPS, SSNPs, or siRNA.
Supplementary Table S2 . Forward (F) and Reverse (R) TNF-α primer sequences.
Primer Sequence
TNF-α F CCACCACGCTCTTTCTGTCTACTG TNF-α R GGGCTACAGGCTTGTCACTCG
Cytotoxicity of SSNPs
Caco-2 and RAW 264. (Fig. 2D and Supplementary Fig. S7 ). Since removal of the components did result in reduced siRNA transport (Fig. 2D) , it was suggested that the paracellular pathway made relatively low contributions to the translocation of SSNPs. For such evaluation, the Caco2-HT29MTX model [6] would be more suitable, because enterocytes are interspersed by goblet cells and mucus is secreted by HT29MTX cells on the apical surface, which more closely mimics the in vivo environment. The mucus layer will increase the distance between SSNPs and the cell monolayers, which may prevent the SSNPs from interacting with tight junctions and thus decrease the tight junction opening capacity. [7] However, the tight junctions are partially interrupted by goblet cells, which will in turn promote the paracellular transport. The mucoadhesive property of SSNPs allows disulfide bonding with the mucus layer as well as cellular membranes, which can facilitate the accumulation of SSNPs in the mucus layer or on cell surfaces to subsequently improve the transcellular uptake in a concentration-driven manner. [8] No It was shown that 24 h after oral administration of TNF-α siRNA containing SSNPs, Scr siRNA-containing SSNPs, blank SSNPs, and naked TNF-α siRNA, the serum (interleukin-1β)
IL-1β, (interleukin-6) IL-6, TNF-α, and (interferon-γ) IFN-γ levels were not significantly increased compared to control mice receiving no treatment (p>0.05, Supplementary Fig. S19 ).
These results preliminary indicated that oral administration of SSNPs would not activate pro-inflammatory cytokines or induce IFN-γ responses.
